Effects of chronic morphine intake on binding of NAD and GABA-benzodiazepine agonists to synaptic membranes

Bulletin of Experimental Biology and Medicine

Volumn 127, Issue 3, 1999, Pages 266-268

  Fomenko, A I ^a   Donchenko, G V ^a   Stepanenko, S P ^a  

^a PALLADIN INSTITUTE OF BIOCHEMISTRY   (Ukraine)

Author keywords

GABA benzodiazepine receptor complex; Morphine; NAD; Vitamin B3

Indexed keywords

EID: 0005201326     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02433352     Document Type: Article

References (11)

1. T. A. Voronina, Farmakol. Toksikol., 44, No. 6, 680-683 (1981).
2. A. I. Fomenko, G. V. Donchenko, A. A. Khalmuradov, and S. P. Stepanenko, Ukr. Biokhim. Zh., 69, No. 2, 46-50 (1997).
3. A. I. Fomenko, P. K. Parkhomets, G. V. Donchenko, and S. P. Stepanenko, Vopr. Med. Khimii, 39, No. 4, 48-50 (1993).
4. A. I. Fomenko, G. V. Chichkovskaya, P. K. Parkhomets, and G. V. Donchenko, Ukr. Biokhim. Zh., 64, No. 6. 109-113 (1992).
5. J. Abita, R. Chicheportiche, H. Shvetz, and M. Lozdunski, Biochemistry, 16, No. 9, 1838-1864 (1977).
6. R. M. Burton, N. O. Kaplan, A. Goldin. Science, 127, No. 3288, 30-31 (1958).
7. Y. Ito and K. Kuriama, Brain Res., 236, No. 2, 351-363 (1982).
8. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. I. Randall, J. Biol. Chem., 193, No. 1, 265-275 (1951).
9. K. Manfred, Neurochem. Int., 5, No. 6, 673-674 (1983).
10. H. Mochler and T. Okada, Science, 198, No. 4320, 849-851 (1977).
11. D. W. Woolley, Science, Ibid., 128, No. 33-34, 1277-1278 (1958).